| 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use … |
2022-8-19 |
2023-2-23 |
|
| Novel macrocyclic antiviral agents |
2022-5-03 |
2022-11-10 |
|
| Benzodiazepine derivatives as rsv inhibitors |
2022-5-03 |
2023-3-23 |
|
| Novel spiropyrrolidine derived antiviral agents |
2022-4-14 |
2023-1-26 |
|
| Novel spiropyrrolidine derived antiviral agents |
2022-4-14 |
2023-2-02 |
|
| Novel spiropyrrolidine derived antiviral agents |
2022-4-14 |
2023-1-29 |
|
| Novel spiropyrrolidine derived antiviral agents |
2022-4-14 |
2023-4-13 |
|
| Novel macrocyclic spiropyrrolidine derived antiviral agents |
2022-4-13 |
2022-12-22 |
|
| Antiviral heterocyclic compounds |
2022-4-13 |
2023-4-13 |
|
| Novel macrocyclic spiropyrrolidine derived antiviral agents |
2022-4-13 |
2022-11-17 |
|
| Antiviral heterocyclic compounds |
2022-3-30 |
2022-6-01 |
|
| Antiviral heterocyclic compounds |
2022-2-24 |
2022-9-01 |
|
| Benzodiazepine derivatives as rsv inhibitors |
2022-1-13 |
2022-7-21 |
|
| Spiropyrrolidine derived compounds, pharmaceutical compositions and uses … |
2021-11-23 |
2022-10-01 |
|
| Novel spiropyrrolidine derived antiviral agents |
2021-11-22 |
2023-4-06 |
|
| Novel spiropyrrolidine derived antiviral agents |
2021-11-22 |
2022-5-27 |
|
| Functionalized peptides as antiviral agents |
2021-11-09 |
2022-6-14 |
2022-6-14 |
| Functionalized heterocycles as antiviral agents |
2021-11-03 |
2023-3-09 |
|
| Antiviral Agents for Hepatitis B (Divisional Application No. 487-2020) |
2021-10-19 |
2022-6-03 |
|
| Heterocyclic compounds as anti-viral agents |
2021-10-18 |
2022-4-28 |
|
| Macrocyclic spiropyrrolidine derived antiviral agents |
2021-9-20 |
2022-5-03 |
2022-5-03 |
| Spiropyrrolidine derived antiviral agents |
2021-9-20 |
2022-5-24 |
2022-5-24 |
| Spiropyrrolidine derived antiviral agents |
2021-9-20 |
2022-5-10 |
2022-5-10 |
| Spiropyrrolidine derived antiviral agents |
2021-9-20 |
2022-7-12 |
2022-7-12 |
| Novel spiropyrrolidine derived antiviral agents |
2021-9-20 |
2022-5-26 |
|
| glecaprevir or a pharmaceutically acceptable salt or ester thereof- prolonged … |
2021-9-16 |
2021-9-16 |
|
| Functionalized peptides as antiviral agents |
2021-8-12 |
2022-2-17 |
|
| Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors |
2021-7-06 |
2022-1-13 |
|
| Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof |
2021-7-02 |
2021-10-29 |
|
| Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and … |
2021-4-13 |
2022-4-21 |
|
| Antiviral heterocyclic compounds |
2021-4-01 |
2022-10-06 |
|
| Antiviral heterocyclic compounds |
2021-4-01 |
2022-11-22 |
2022-11-22 |
| Functionalized heterocycles as antiviral agents |
2021-3-16 |
2021-5-31 |
|
| Functionalized heterocyclic compounds as antiviral agents |
2021-3-15 |
2021-9-23 |
|
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2021-3-10 |
2023-1-24 |
2023-1-24 |
| Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof |
2021-2-26 |
2021-8-26 |
|
| Heterocyclic compounds as anti-viral agents, pharmaceutical compositions and … |
2021-1-25 |
2021-11-01 |
|
| COMPOUNDS DERIVED FROM 2,3-DIHYDROFURO[2,3-c]PYRIDINE AS ANTIVIRAL AGENTS |
2021-1-21 |
2022-4-13 |
|
| Hepatitis b antiviral agents |
2021-1-07 |
2021-7-29 |
|
| Combination pharmaceutical agents as rsv inhibitors |
2020-11-10 |
2022-10-13 |
|
| Functionalized heterocycles as antiviral agents |
2020-9-16 |
2021-3-25 |
|
| HETEROCYCLIC ANTIVIRAL COMPOUNDS |
2020-7-16 |
2022-6-28 |
|
| ANTIVIRAL HETEROCYCLIC COMPOUNDS |
2020-7-15 |
2022-8-31 |
|
| Substituted heterocycles as antiviral agents |
2020-7-10 |
2021-1-14 |
|
| Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents |
2020-6-04 |
2022-10-18 |
2022-10-18 |
| Hepatitis b antiviral agents |
2020-6-04 |
2020-12-10 |
|
| Hepatitis b antiviral agents |
2020-6-03 |
2020-12-10 |
|
| Isoxazole derivatives as FXR agonists and methods of use thereof |
2020-5-11 |
2023-1-17 |
2023-1-17 |
| Processes for the resolution of benzodiazepin-2-one and benzodiazepin-2-one … |
2020-5-07 |
2022-7-01 |
|
| Process for preparation of sulfonyl carbamate bile acid derivatives |
2020-4-21 |
2021-3-30 |
2021-3-30 |
| Heterocyclic compounds as rsv inhibitors |
2020-4-07 |
2020-10-15 |
|
| Hepatitis b antiviral agents |
2020-3-30 |
2020-10-08 |
|
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2020-3-24 |
2020-10-01 |
|
| BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS |
2020-3-17 |
2021-9-29 |
|
| INHIBITORS OF MACROCYCLIC PROLINE-DERIVED HCV SERINE PROTEASES |
2020-3-02 |
2021-9-22 |
|
| Process for preparation of sulfonylurea bile acid derivatives |
2020-2-07 |
2020-8-06 |
|
| HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS |
2019-11-20 |
2021-7-14 |
|
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2019-11-19 |
2020-5-28 |
|
| Isoxazole analogs as FXR agonists and methods of use thereof |
2019-9-13 |
2021-6-15 |
2021-6-15 |
| Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and … |
2019-8-21 |
2020-2-27 |
|
| Process for the preparation of benzodiazepine derivatives |
2019-8-16 |
2021-2-16 |
|
| Processes for the preparation of benzodiazepine derivatives |
2019-8-15 |
2019-10-31 |
|
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2019-5-01 |
2019-11-07 |
|
| Heterocyclic compounds as RSV inhibitors |
2019-4-10 |
2021-4-13 |
2021-4-13 |
| Hepatitis B antiviral agents |
2019-3-27 |
2020-8-04 |
2020-8-04 |
| Isoxazole derivatives as fxr agonists and methods of use thereof |
2019-2-11 |
2019-8-15 |
|
| HETEROCYCLES SUBSTITUTED AS ANTIVIRAL AGENTS |
2019-1-21 |
2020-8-05 |
|
| HETEROCICLES REPLACED AS ANTIVIRAL AGENTS |
2019-1-21 |
2019-7-31 |
|
| Isoxazole analogs as fxr agonists and methods of use thereof |
2018-12-12 |
2019-6-27 |
|
| ANTIVIRAL AGENTS AGAINST HEPATITIS B |
2018-12-06 |
2019-4-30 |
|
| ANTIVIRAL AGENTS AGAINST HEPATITIS B |
2018-12-06 |
2019-4-30 |
|
| ANTIVIRAL AGENTS AGAINST HEPATITIS B |
2018-12-05 |
2020-6-24 |
|
| Hepatitis B antiviral agents |
2018-11-29 |
2020-7-07 |
2020-7-07 |
| Azepin-2-one derivatives as rsv inhibitors |
2018-11-13 |
2019-5-23 |
|
| PHARMACEUTICAL AGENTS AS RSV INHIBITORS FOR USE IN COMBINATION |
2018-9-28 |
2019-11-27 |
|
| Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and … |
2018-8-27 |
2020-3-24 |
2020-3-24 |
| Heterocyclic compounds as rsv inhibitors |
2018-8-10 |
2019-2-07 |
|
| MACROCYCLIC INHIBITERS OF SERINE PRODUCTION OF HEPATITIS C |
2018-7-16 |
2019-12-11 |
|
| Heterocyclic compounds as rsv inhibitors |
2018-6-29 |
2019-1-03 |
|
| Heterocyclic compounds as RSV inhibitors |
2018-6-29 |
2020-12-01 |
2020-12-01 |
| Benzimidazole derivatives |
2018-6-13 |
2020-8-25 |
2020-8-25 |
| Aryldiazepine derivatives as RSV inhibitors |
2018-6-06 |
2020-8-25 |
2020-8-25 |
| Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof |
2018-5-24 |
2018-12-20 |
|
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2018-5-24 |
2019-10-22 |
2019-10-22 |
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2018-5-24 |
2019-4-02 |
2019-4-02 |
| Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
2018-5-14 |
2018-11-15 |
|
| Bile acid analogs as fxr/tgr5 agonists and methods of use thereof |
2018-4-06 |
2018-8-24 |
|
| Bile acid analogs as fxr/tgr5 agonists and methods of use thereof |
2018-3-30 |
2018-8-17 |
|
| Bile acid analogs an fxr/tgr5 agonists and methods of use thereof |
2018-3-12 |
2018-7-27 |
|
| Bile acid derivatives as fxr agonists and methods of use thereof |
2018-2-14 |
2018-8-23 |
|
| Heteroaryldiazepine derivatives as rsv inhibitors |
2018-1-05 |
2018-7-12 |
|
| Urea-containing isoxazole derivatives as FXR agonists and methods of use … |
2017-10-25 |
2020-3-24 |
2020-3-24 |
| Isoxazole derivatives as fxr agonists and methods of use thereof |
2017-5-17 |
2017-11-23 |
|
| Isoxazole Analogs as FXR Agonists and Methods of Use Thereof |
2017-5-17 |
2017-11-23 |
|
| Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof |
2017-5-17 |
2017-11-23 |
|
| Isoxazole derivatives as fxr agonists and methods of use thereof |
2017-4-26 |
2017-10-26 |
|
| Isoxazole derivatives as fxr agonists and methods of use thereof |
2017-4-26 |
2017-11-02 |
|
| Isoxazole derivatives as fxr agonists and methods of use thereof |
2017-4-26 |
2017-10-26 |
|
| Hepatitis b antiviral agents |
2017-3-06 |
2021-8-03 |
|
| Benzoic Acid Derivatives of Bile Acid as FXR/TGR5 Agonists and Methods of Use … |
2017-2-22 |
2017-8-24 |
|